Sharif Muhammad Ashraf, Mamoon Nadira, Mushtaq Sajid, Khadim Muhammad Tahir
Department of Histopathology, Armed Forces Institute of Pathology, Rawalpindi.
J Coll Physicians Surg Pak. 2009 Feb;19(2):99-103.
To determine the morphological profile and association of HER-2/neu expression with histological prognostic markers and hormonal receptor expression in female breast carcinoma in Northern Pakistan.
Cross-sectional, observational study.
Department of Histopathology, Armed Forces Institute of Pathology, Rawalpindi, from January 2004 to May 2007.
A total of 535 patients of primary operable female breast carcinoma with hormonal profile and biological status were included in the study. Patient's age, microscopic tumour size, tumour grade, lymph node status, Estrogen Receptor (ER), Progesterone Receptor (PR) and joint ER/PR status were evaluated and their association was determined with HER-2/neu expression using the x2 test for univariate analysis.
Out of 535 cases, there were 481 (89.9%) cases of infiltrating ductal carcinoma with mean age of 48 years and mean tumour size of 4.4 cm. Tumour grade II was seen in 68% cases and lymph node metastases were present in 65% cases. HER-2/neu expression was seen in 31% cases, while ER and PR expression was seen in 72.3% and 62.6% respectively. ER and PR showed inverse association with HER-2/neu while positive association was seen with lymph node metastases (p < 0.05). No association was seen between tumour size and tumour grade. Joint ER and PR expression also showed a higher number (73.5%) of HER-2/neu negative cases.
HER-2/neu, ER and PR expression is comparable to the West with inverse association with ER and PR and positive association with lymph node metastases. Since HER-2/neu expression is variable in carcinomas with different tumour characteristics, it is not possible to predict hormone receptor expression in all the cases.
确定巴基斯坦北部女性乳腺癌中HER-2/neu表达的形态学特征及其与组织学预后标志物和激素受体表达的相关性。
横断面观察性研究。
2004年1月至2007年5月,拉瓦尔品第武装部队病理研究所组织病理学系。
本研究共纳入535例具有激素谱和生物学状态的原发性可手术女性乳腺癌患者。评估患者的年龄、显微镜下肿瘤大小、肿瘤分级、淋巴结状态、雌激素受体(ER)、孕激素受体(PR)及联合ER/PR状态,并使用x2检验进行单因素分析,确定它们与HER-2/neu表达的相关性。
535例病例中,有481例(89.9%)为浸润性导管癌,平均年龄48岁,平均肿瘤大小4.4 cm。68%的病例为II级肿瘤,65%的病例有淋巴结转移。31%的病例可见HER-2/neu表达,而ER和PR表达分别见于